Brief: InVivo Therapeutics posts Q3 loss $0.09/shr
Nov 4 (Reuters) - InVivo Therapeutics Holdings Corp NVIV.O : * Reports 2015 third quarter financial results and business update * Q3 loss per share $0.09 * Q3 adjusted loss per share $0.22 excluding items * Says "anticipate our cash position will last US into the fourth quarter of 2016" * Source text for Eikon urn:newsml:reuters.com:*:nBwby7rpZa * Further company coverage NVIV.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR